158 related articles for article (PubMed ID: 18397710)
1. Two consecutive episodes of acute hepatitis C with different genotypes in a hemodialysis patient responsive to PEG-interferon monotherapy.
Lederer S; Zachoval R; Hasholzner U; Schiffl H
Clin Nephrol; 2008 Apr; 69(4):313-6. PubMed ID: 18397710
[TBL] [Abstract][Full Text] [Related]
2. Pegylated interferon alfa-2a monotherapy for hemodialysis patients with acute hepatitis C.
Liu CH; Liang CC; Liu CJ; Lin JW; Chen SI; Hung PH; Tsai HB; Lai MY; Chen PJ; Chen DS; Kao JH
Clin Infect Dis; 2010 Sep; 51(5):541-9. PubMed ID: 20645865
[TBL] [Abstract][Full Text] [Related]
3. Treatment of hepatitis C in hemodialysis patients with pegylated interferon alpha-2a as monotherapy.
Sikole A; Dzekova P; Selja N; Gaseva M; Nikolov IG; Zabzun M; Muharemi S; Asani A; Amitov V; Mena S; Grunevska V; Ivanovski L; Polenakovic M
Ren Fail; 2007; 29(8):961-6. PubMed ID: 18067041
[TBL] [Abstract][Full Text] [Related]
4. Multicenter study of pegylated interferon α-2a monotherapy for hepatitis C virus-infected patients on hemodialysis: REACH study.
Kikuchi K; Akiba T; Nitta K; Masakane I; Ando R; Izumi N; Atsukawa M; Yamazaki C; Kato F; Hotta N; Tominaga Y; Orito E; Hora K; Nagasawa M; Kasahara H; Kawaguchi M; Kimura H; Ikebe N; Kawanishi H; Moriishi M; Shigemoto K; Harada T; Hirakata H; Watanabe H; Nosaki T; Tsubouchi H; Imawari M; Akizawa T
Ther Apher Dial; 2014 Dec; 18(6):603-11. PubMed ID: 25196061
[TBL] [Abstract][Full Text] [Related]
5. [Treatment in chronic renal failure].
Curciarello J; Fernández JL; Silva M
Acta Gastroenterol Latinoam; 2005 Jun; 35 Suppl 1():S55-7. PubMed ID: 20214305
[No Abstract] [Full Text] [Related]
6. Pegylated interferon alpha therapy in acute hepatitis C: relation to hepatitis C virus-specific T cell response kinetics.
Kamal SM; Ismail A; Graham CS; He Q; Rasenack JW; Peters T; Tawil AA; Fehr JJ; Khalifa Kel S; Madwar MM; Koziel MJ
Hepatology; 2004 Jun; 39(6):1721-31. PubMed ID: 15185314
[TBL] [Abstract][Full Text] [Related]
7. Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial.
Liu CH; Huang CF; Liu CJ; Dai CY; Liang CC; Huang JF; Hung PH; Tsai HB; Tsai MK; Chen SI; Lin JW; Yang SS; Su TH; Yang HC; Chen PJ; Chen DS; Chuang WL; Yu ML; Kao JH
Ann Intern Med; 2013 Dec; 159(11):729-38. PubMed ID: 24297189
[TBL] [Abstract][Full Text] [Related]
8. Successful pegylated interferon alpha2a monotherapy for hepatitis C virus infection in a transplanted patient who relapsed after the preceding course.
Ichikawa T; Taura N; Miyaaki H; Matsuzaki M; Eguchi S; Takatsuki M; Kanematsu T; Nakao K
Transpl Infect Dis; 2011 Aug; 13(4):438-40. PubMed ID: 21309967
[No Abstract] [Full Text] [Related]
9. Summaries for patients. Pegylated interferon with or without ribavirin for patients with hepatitis C receiving hemodialysis.
Ann Intern Med; 2013 Dec; 159(11):I-14. PubMed ID: 24297207
[No Abstract] [Full Text] [Related]
10. [Treatment of chronic hepatitis C virus infection in hemodialysis patients].
Kaya S
Mikrobiyol Bul; 2008 Jul; 42(3):525-34. PubMed ID: 18822900
[TBL] [Abstract][Full Text] [Related]
11. Superiority of standard interferon-alpha2b compared to pegylated interferon-alpha2b (12 kDa) in a hemodialysis patient with chronic hepatitis C?
Potthoff A; Wiegand J; Lüth JB; Wedemeyer H; Manns MP; Tillmann HL
Clin Nephrol; 2005 Mar; 63(3):232-5. PubMed ID: 15786827
[TBL] [Abstract][Full Text] [Related]
12. Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.
Rocha CM; Perez RM; Narciso JL; Ferreira AP; Lemos LB; Medina-Pestana JO; Silva AE; Ferraz ML
Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):119-23. PubMed ID: 17272996
[TBL] [Abstract][Full Text] [Related]
13. Safety and Efficacy of Pegylated Interferon Alpha-2b Monotherapy in Hepatitis C Virus-Infected Children with End-Stage Renal Disease on Hemodialysis.
Mogahed EA; Abdelaziz H; Helmy H; Ghita H; Abdel Mawla MA; Hassanin F; Fadel FI; El-Karaksy H
J Interferon Cytokine Res; 2016 Dec; 36(12):681-688. PubMed ID: 27656950
[TBL] [Abstract][Full Text] [Related]
14. Safety and effectiveness of response-guided therapy using pegylated interferon and ribavirin for chronic hepatitis C virus infection in patients on maintenance dialysis.
Goel A; Bhadauria DS; Kaul A; Prasad N; Gupta A; Sharma RK; Rai P; Aggarwal R
Nephrology (Carlton); 2017 Sep; 22(9):706-711. PubMed ID: 27286895
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C trials that combine investigational agents with pegylated interferon should be stratified by interleukin-28B genotype.
Thompson AJ; Muir AJ; Sulkowski MS; Patel K; Tillmann HL; Clark PJ; Naggie S; Fellay J; Ge D; McCarthy JJ; Goldstein DB; McHutchison JG
Hepatology; 2010 Dec; 52(6):2243-4. PubMed ID: 20890887
[No Abstract] [Full Text] [Related]
16. Pegylated interferon for treatment in hemodialysis patients with chronic hepatitis C.
Koksal I
J Gastroenterol Hepatol; 2006 Mar; 21(3):491-4. PubMed ID: 16638088
[No Abstract] [Full Text] [Related]
17. Treatment of acute hepatitis C-how to explain the differences?
Wedemeyer H; Cornberg M; Wiegand J; Jäckel E; Manns MP
Gastroenterology; 2006 Aug; 131(2):682-3; author reply 683-4. PubMed ID: 16890627
[No Abstract] [Full Text] [Related]
18. Cure of acute hepatitis C in HIV co-infection?
Ristig MB; Tebas P; Gandy I; Qaqish R; Aberg JA
J Clin Gastroenterol; 2004 Mar; 38(3):303. PubMed ID: 15128087
[No Abstract] [Full Text] [Related]
19. PEG-interferon in acute and chronic hepatitis C: a review.
Palumbo E
Am J Ther; 2009; 16(6):573-8. PubMed ID: 19433975
[TBL] [Abstract][Full Text] [Related]
20. Interferon treatment for patients with chronic hepatitis C complicated with chronic renal failure receiving hemodialysis.
Kojima A; Kakizaki S; Hosonuma K; Yamazaki Y; Horiguchi N; Sato K; Kitahara T; Mori M
J Gastroenterol Hepatol; 2013 Apr; 28(4):690-9. PubMed ID: 23302054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
